MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.anpedi.2018.07.007

Медицинская библиотека · Anales de pediatria · 2018

[Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents].

Quintero Jesús, Juampérez Javier, Julio Ecaterina, Cabello Vanessa, Mercadal-Hally Maria, Soler-Palacín Pere, Segarra Óscar, Rodrigo Carlos

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Hepatitis C virus infection is world health problem. The aim of this study was to assess the safety and efficacy of ledipasvir/sofosbuvir combination in chronic Hepatitis C Virus (HCV) genotype 1 and 4 infection in paediatric patients.

METHODS

Eligible patients to be treated with ledipasvir/sofosbuvir were patients from 6 to 18 years old with a chronic HCV genotype 1 or 4 infection. The duration and doses of antiviral drugs were changed depending on patient age, fibrosis stage, and PEGylated interferon+ribavirin experience status. The primary efficacy endpoint was the percentage of patients with a sustained virological response 12 weeks post-treatment.

RESULTS

A total of nine patients (7 males) with a median age of 14.8 years (8.48-17.91) were treated with ledipasvir/sofosbuvir combination. Five patients received previous treatment with PEGylated interferon+ribavirin during a median of 8.5 months (3-12 months). Eight patients had some degree of fibrosis (1 patient presented with F1, three patients F2, 2 patients F3, and 2 patients F4). The median pre-treatment viral load was 6.2 Log [5.9-6.8] with the HCV RNA becoming negative six weeks after starting the treatment in 100% of the patients. All patients maintained a sustained viral response at 12 weeks. Three patients (33.3%) had some type of adverse effect (2 headache and one oral thrush). The median post-treatment follow-up was 24 weeks (12-104).

CONCLUSIONS

Treatment with ledipasvir/sofosbuvir in paediatric patients with chronic HCV infection genotype 1 and 4 is safe and effective with SVR12 and similar to those reported in adults.

Для цитирования: Quintero Jesús, Juampérez Javier, Julio Ecaterina, Cabello Vanessa, Mercadal-Hally Maria, Soler-Palacín Pere, Segarra Óscar, Rodrigo Carlos. [Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents].. Anales de pediatria. 2018. DOI: 10.1016/j.anpedi.2018.07.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.